MPTP
| Names | |
|---|---|
| Preferred IUPAC name 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | |
| Identifiers | |
| 3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.044.475 | 
| EC Number | 
 | 
| KEGG | |
| MeSH | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C12H15N | |
| Molar mass | 173.259 g·mol−1 | 
| Melting point | 40 °C (104 °F; 313 K) | 
| Boiling point | 128 to 132 °C (262 to 270 °F; 401 to 405 K) 12 Torr | 
| Slightly soluble | |
| Hazards | |
| NFPA 704 (fire diamond) | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is an organic compound. It is classified as a tetrahydropyridine. It is of interest as a precursor to the monoaminergic neurotoxin MPP+, which causes permanent symptoms of Parkinson's disease by destroying dopaminergic neurons in the substantia nigra of the brain. It has been used to study disease models in various animals.
While MPTP itself has no psychoactive effects, the compound may be accidentally produced during the manufacture of MPPP, a synthetic opioid drug with effects similar to those of morphine and pethidine (meperidine). The Parkinson-inducing effects of MPTP were first discovered following accidental injection as a result of contaminated MPPP.